Affymetrix at JPMorgan Global Healthcare Conference
Thursday, January 10, 2013 8:30 a.m. PT
Webcast Presentation
18:56
"Molecular pathology, I won't really touch on but we are doing some very exciting things in combination with eBioscience on combining our gene expression technology and their flow cytometry which could create some very unique and exciting podu, ah opportunities and they have flow based leukemia lymphoma assays as well....."
Of interest?
- Forums
- ASX - By Stock
- affymetrix
Affymetrix at JPMorgan Global Healthcare ConferenceThursday,...
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.79M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 2.0¢ | $12.09K | 604.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1032452 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 143537 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1032452 | 0.020 |
16 | 2467401 | 0.019 |
7 | 2493502 | 0.018 |
5 | 1724748 | 0.017 |
2 | 482000 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 143537 | 3 |
0.022 | 425988 | 6 |
0.023 | 540459 | 7 |
0.024 | 141966 | 2 |
0.025 | 202146 | 4 |
Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online